Los Angeles, CA, United States of America

Xinkai Xie



 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Xinkai Xie

Introduction

Xinkai Xie is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for producing simvastatin and related compounds. With a total of 8 patents to his name, Xie's work has had a considerable impact on the industry.

Latest Patents

Xie's latest patents include innovative methods and materials for making simvastatin and related compounds. One of his notable inventions focuses on the production of simvastatin and huvastatin, detailing methods that facilitate the conversion of lovastatin to simvastatin with minimal modifications. Another patent involves the engineering of variant LovD polypeptides, which can enhance the efficiency of simvastatin production.

Career Highlights

Xie is affiliated with the University of California, where he continues to advance research in pharmaceutical sciences. His work has not only contributed to the understanding of simvastatin production but has also paved the way for further innovations in the field.

Collaborations

Xie collaborates with esteemed colleagues such as Yi Tang and Xue Gao, who share his commitment to advancing pharmaceutical research. Their combined expertise fosters an environment of innovation and discovery.

Conclusion

Xinkai Xie's contributions to the field of pharmaceuticals through his patents and research at the University of California highlight his role as a leading inventor. His innovative methods for producing simvastatin and related compounds demonstrate the importance of research and collaboration in driving advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…